I think the problem is it's flying under the radar due to its low market cap and the fact that glaucoma is not a popular area to invest in for the ASX get rich quick crowd.
The next potential catalyst is the audited results in August, I'm really hoping they give a further sales update as I suspect it will be good & hopefully give the SP a decent boost over 30c
I think the problem is it's flying under the radar due to...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $73.06K | 304.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342553 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 50108 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |